Medical Subject Headings / 医学主题词表

Last uploaded: September 7, 2023
Preferred Name

nilotinib

Synonyms

Tasigna

ID

http://purl.bioontology.org/ontology/MESH/C498826

altLabel

Tasigna

nilotinib hydrochloride dihydrate

benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate (1:2:2)

AMN107

4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide

nilotinib hydrochloride anhydrous

benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride (1:1)

benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate (2:2:3)

benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate (1:1:2)

nilotinib hydrochloride sesquihydrate

nilotinib hydrochloride monohydrate

nilotinib dihydrochloride dihydrate

AMN 107

benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate

nilotinib hydrochloride

nilotinib hydrochloride hydrate

AMN-107

cui

C5564928

C1879514

C4083099

C2987005

C1567379

C1966375

C1721377

C5564929

C5564930

HM

D011743

II

D011505/Q000037

Inverse of RB

WM15I3PF3G

0

FQV3UFL546

K37N7BYX3X

5JHU0N1R6K

Y37S7HA3BC

F41401512X

LT

TRD

Mapped to

http://purl.bioontology.org/ontology/MESH/D011743

MDA

20050406

MeSH Frequency

1374

MMR

20220113

notation

C498826

prefLabel

nilotinib

RR

WM15I3PF3G

FQV3UFL546

K37N7BYX3X

5JHU0N1R6K

Y37S7HA3BC

SC

1

Scope Statement

antineoplastic agent

SRC

Cancer Cell 2005 Feb;7(2):117-9

TERMUI

T001117095

T001117089

T001117098

T669833

T001117085

T001117100

T001117096

T001117087

T001117093

T635305

T789521

T001117088

T001117099

T001117094

T001117086

T001117092

T676405

T001117097

TH

NLM (2006)

NLM (2011)

FDA SRS (2017)

USAN (19XX)

NLM (2022)

NLM (2005)

INN (19XX)

tui

T109

T121

Delete Subject Author Type Created
No notes to display
Create New Mapping

Delete Mapping To Ontology Source
http://purl.obolibrary.org/obo/DRON_00018985 Coronavirus Infectious Disease Ontology / 冠状病毒感染性疾病本体 LOOM
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000176124 Ontology of Drug Adverse Events / 药物不良反应本体 LOOM
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000176124 Coronavirus Infectious Disease Ontology / 冠状病毒感染性疾病本体 LOOM
http://purl.obolibrary.org/obo/CHEBI_52172 Chemical Entities of Biological Interest Ontology / 生物相关的化学实体本体 LOOM
http://purl.obolibrary.org/obo/CHEBI_52172 The Drug Ontology / 药物本体 LOOM
http://purl.obolibrary.org/obo/CHEBI_52172 Coronavirus Infectious Disease Ontology / 冠状病毒感染性疾病本体 LOOM
http://purl.obolibrary.org/obo/CHEBI_52172 Experimental Factor Ontology / 实验性因素本体 LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C48375 National Cancer Institute Thesaurus / 美国国家癌症研究所词典 LOOM
http://purl.bioontology.org/ontology/ATC/L01EA03 Anatomical Therapeutic Chemical Classification / 解剖学治疗学及化学分类系统 CUI
http://purl.bioontology.org/ontology/ATC/L01EA03 Anatomical Therapeutic Chemical Classification / 解剖学治疗学及化学分类系统 LOOM